Search alternatives:
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
681
-
682
-
683
-
684
Inhibition of GLS1 decreases the proportion of CCR6 and CXCR3 expressing CD4<sup>+</sup> T cells.
Published 2016“…(B–C) The proportion of CCR6 expressing cells at day 3 (left) and day 5 (right) under normoxia (black bars) and hypoxia (grey bars) in the presence (+) and absence (-) of 25 μM BPTES and 50 μM 968. BPTES and 968 significantly decrease the proportion of CCR6 expressing cells under normoxia both at day 3 and 5, whereas 968 but not BPTES decrease the proportion of CCR6 expressing cells under hypoxia both at day 3 and 5. …”
-
685
Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration.
Published 2025“…<b>(B)</b> A significant decrease in the proliferative clonal capacity of U251MG colonies was observed with 50ΜM and 100ΜM SHG-44 treatment. …”
-
686
-
687
Decreased phosphorylation of EIF2α underlies the impairment of arsenite-induced SG formation in LSM12-depleted cells.
Published 2020“…All underlying numerical values are available in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3001002#pbio.3001002.s016" target="_blank">S1 Data</a>. …”
-
688
Capsaicin, pyridoxine, vincristine sulfate and ionomycin significantly decreased axon length ratio but only pyridoxine had no impact on neurotoxicity.
Published 2024“…At a lower dose, 50 μM Pyr, did not induce significant change in axon length ratio over time and between PBS control in both female and male rat DRGs. …”
-
689
-
690
-
691
-
692
-
693
-
694
-
695
-
696
-
697
-
698
Numbers of all fractures, arranged in order of decreasing mean age and with proportion of each of the fracture types in patients over 50, 65, and 75 years of age.
Published 2020“…<p>Numbers of all fractures, arranged in order of decreasing mean age and with proportion of each of the fracture types in patients over 50, 65, and 75 years of age.…”
-
699
-
700